Shandong Jincheng Pharmaceutical Group Co., Ltd. Class A 300233

SZSE · China · Health Technology

CNY 13.60+0.40 (+3.03%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Shandong Jincheng Pharmaceutical Group Co., Ltd. Class A 300233

SZSE · China · Health Technology

CNY 13.60+0.40 (+3.03%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-2.44% · 6MFull-screen chart

Open CNY 13.33High CNY 13.79Low CNY 13.24Close CNY 13.60Volume 11.10M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 13.20
Day range: CNY 13.24 – CNY 13.79
52-week range: CNY 11.58 – CNY 19.24
Volume: 11.10M
Market cap: CNY 5.13B
P/E (TTM): 35.8
Dividend yield (annualized): 1.84%
Avg. volume (1Y): 9.61M

Performance

1 week

+0.67%

1 month

+2.87%

3 months

+2.87%

6 months

-6.90%

Year to date

-4.44%

1 year

-26.17%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: China
Exchange: SZSE
Shares outstanding: 379.33M
Employees: 3,515
ISIN: CNE100001500
Beta: 1.19

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceMay 12, 2026

Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma

Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) ("Jincheng Pharma"), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.